Raymond James & Associates’s Diversified Healthcare Trust DHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-28,717
Closed -$28K 3951
2022
Q3
$28K Buy
28,717
+1,450
+5% +$2.32K ﹤0.01% 3763
2022
Q2
$50K Hold
27,267
﹤0.01% 3785
2022
Q1
$87K Sell
27,267
-737
-3% -$2.25K ﹤0.01% 3851
2021
Q4
$87K Sell
28,004
-5,295
-16% -$17.1K ﹤0.01% 3883
2021
Q3
$113K Sell
33,299
-6,141
-16% -$23.2K ﹤0.01% 3812
2021
Q2
$165K Buy
39,440
+972
+3% +$4.01K ﹤0.01% 3733
2021
Q1
$184K Buy
38,468
+5,330
+16% +$24.5K ﹤0.01% 3639
2020
Q4
$137K Sell
33,138
-1,088
-3% -$4.29K ﹤0.01% 3505
2020
Q3
$120K Buy
34,226
+2,250
+7% +$8.78K ﹤0.01% 3348
2020
Q2
$141K Sell
31,976
-2,750
-8% -$9.72K ﹤0.01% 3221
2020
Q1
$126K Buy
34,726
+2,354
+7% +$15.4K ﹤0.01% 3163
2019
Q4
$273K Sell
32,372
-5,767
-15% -$48.6K ﹤0.01% 3135
2019
Q3
$353K Buy
38,139
+266
+0.7% +$2.29K ﹤0.01% 2902
2019
Q2
$313K Sell
37,873
-1,162
-3% -$9.68K ﹤0.01% 2988
2019
Q1
$460K Sell
39,035
-7,721
-17% -$98.9K ﹤0.01% 2714
2018
Q4
$548K Sell
46,756
-17,801
-28% -$264K ﹤0.01% 2496
2018
Q3
$1.13M Buy
64,557
+8,493
+15% +$156K ﹤0.01% 2159
2018
Q2
$1.01M Buy
56,064
+1,280
+2% +$21.2K ﹤0.01% 2205
2018
Q1
$858K Sell
54,784
-14,202
-21% -$236K ﹤0.01% 2245
2017
Q4
$1.32M Buy
68,986
+3,838
+6% +$73.5K ﹤0.01% 1965
2017
Q3
$1.27M Buy
65,148
+24,313
+60% +$474K ﹤0.01% 1951
2017
Q2
$835K Sell
40,835
-12,462
-23% -$266K ﹤0.01% 2141
2017
Q1
$1.08M Buy
53,297
+2,457
+5% +$48.2K ﹤0.01% 1929
2016
Q4
$962K Sell
50,840
-6,945
-12% -$135K ﹤0.01% 1938
2016
Q3
$1.31M Sell
57,785
-6,308
-10% -$140K ﹤0.01% 1714
2016
Q2
$1.33M Sell
64,093
-1,684
-3% -$31.4K ﹤0.01% 1568
2016
Q1
$1.18M Buy
65,777
+6,418
+11% +$100K ﹤0.01% 1589
2015
Q4
$881K Sell
59,359
-3,916
-6% -$58.5K ﹤0.01% 1701
2015
Q3
$1.02M Sell
63,275
-25,493
-29% -$421K ﹤0.01% 1589
2015
Q2
$1.54M Sell
88,768
-816,579
-90% -$16.2M 0.01% 1473
2015
Q1
$19.9M Buy
905,347
+66,381
+8% +$1.48M 0.09% 251
2014
Q4
$18.4M Buy
838,966
+22,869
+3% +$501K 0.09% 247
2014
Q3
$16.9M Buy
816,097
+363,600
+80% +$8.24M 0.1% 225
2014
Q2
$10.9M Buy
452,497
+26,766
+6% +$625K 0.07% 327
2014
Q1
$9.48M Buy
425,731
+39,732
+10% +$869K 0.07% 336
2013
Q4
$8.5M Buy
385,999
+32,240
+9% +$746K 0.06% 340
2013
Q3
$8.18M Buy
353,759
+21,357
+6% +$517K 0.07% 323
2013
Q2
$8.54M Buy
+332,402
New +$9.02M 0.08% 284

Other funds holding DHC

Raymond James & Associates's DHC Position: Q4 2022 in Review

Raymond James & Associates sold out of Diversified Healthcare Trust (DHC) in Q4 2022, closing a stake of 28,717 shares — an estimated $28K sold.

Raymond James & Associates first reported a position in DHC in Q2 2013 and held it in 38 quarters. The position peaked at $19.9M in Q1 2015. 182 funds tracked by Wall St. Rank hold DHC as of Q4 2022.

  • Raymond James & Associates reported no remaining Diversified Healthcare Trust position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 28,717 Diversified Healthcare Trust shares in Q4 2022, an estimated $28K.
  • Raymond James & Associates first reported a position in Diversified Healthcare Trust in Q2 2013 and held it in 38 quarters.
  • Raymond James & Associates's Diversified Healthcare Trust position peaked at $19.9M in Q1 2015.
  • 182 funds tracked by Wall St. Rank held Diversified Healthcare Trust as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.